west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "根治性肝切除" 3 results
  • 根治性肝切除术后联合使用索拉非尼一例

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • Impact of blood glucose level after open radical hepatectomy on early recurrence of hepatocellular carcinoma

    ObjectiveTo investigate the impact of elevated fasting blood glucose (FBG) level after open radical hepatectomy on the early recurrence of hepatocellular carcinoma (HCC).MethodsThe clinical data of 112 patients with HCC who underwent the open radical hepatecomy from January 2013 to December 2014 in the Affiliated Hospital of Qingdao University were retrospectively analyzed. After the radical resection of HCC, 86 patients with level of FBG 3.9–6.1 mmol/L and 26 patients with level of FBG≥6.1 mmol/L were design into a normal FBG group and an elevated FBG group, respectively. The recurrence rates of HCC were compared between the two groups at 1- and 2-year after the opreation.ResultsThere were no significant differences between the 2 groups in the gender, age, history of alcohol drinking, hepatitis B history, preoperative ALT, AST, AFP and Child-Pugh classification, scope of hepatectomy, intraoperative hemorrhage, hepatic blood flow occlusion, diameter of maximal tumor, histopathological differentiation, tumor number, cirrhosis, satellite lesion, postoperative adjuvant TACE treatment or not (P>0.05). The postoperative 1- and 2-year recurrence rates of HCC were 19.8% (17/86) and 33.7% (29/86) in the normal FBG group and 42.3% (11/26) and 61.5% (16/26) in the elevated FBG group, respectively, showing significant differences between the 2 groups (P<0.05). The results of multivariate analysis showed that the level of FBG≥6.1 mmol/L, low histopathological differentiation, and no postoperative TACE treatment were the independent risk factors affecting tumor-free survival rate after the open radical resection of HCC (P<0.05). ConclusionsElevated FBG level after open radical resection has a stimulative effect on early recurrence of HCC. As a result, monitoring and controlling of FBG level after operation is helpful in decreasing early recurrence rate of patients with HCC.

    Release date:2020-12-30 02:01 Export PDF Favorites Scan
  • Research advances in early postoperative recurrence of hepatocellular carcinoma with microvascular invasion

    Objective To explore the impact of microvascular invasion (MVI) on the survival prognosis of patients after radical hepatectomy for hepatocellular carcinoma, to analyze its related risk factors, and to provide reference and support for the treatment of early postoperative recurrence. MethodsBy searching domestic and international medical literature databases, we screened studies related to MVI in hepatocellular carcinoma, focusing on the definition, grading, risk factors, preoperative prediction methods, and postoperative treatment strategies of MVI, and summarized the results of the existing studies. ResultsMVI is widely recognized as a significant risk factor for the intrahepatic metastasis and early postoperative recurrence of hepatocellular carcinoma. This paper aims to comprehensively investigate the characteristics of MVI and its impact on the postoperative recurrence of hepatocellular carcinoma, with a specific focus on identifying the risk factors associated with MVI. The study encompasses cutting-edge fields such as imaging genomics and genomics, with the objective of providing a scientific foundation for preoperative evaluation. Additionally, the paper examines postoperative treatment strategies for MVI, including comprehensive options such as local therapy, systemic therapy, and antiviral therapy, in order to establish a multidimensional intervention pathway for patients with hepatocellular carcinoma. The ultimate goal is to enhance prognosis and reduce recurrence rates. In the future, further refinement of MVI-related risk factors and optimization of preoperative prediction models, along with the development of personalized postoperative treatment plans, will be crucial areas of focus for hepatocellular carcinoma research and clinical practice. ConclusionsThe study of MVI and its targeted treatment strategies are important for reducing the postoperative recurrence rate of hepatocellular carcinoma and improving patient survival. The preoperative prediction model and postoperative treatment plan should be optimized in the future to provide more effective treatment reference for patients.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content